Inactive Instrument
Finch Therapeutics Group, Inc. Share Price
Stocks
FNCHQ
US31773D2009
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -1.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Lance Thibault
DFI | Director of Finance/CFO | 60 | 16/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Domenic Ferrante
BRD | Director/Board Member | 60 | 25/09/2019 |
Chris Shumway
CHM | Chairman | 60 | - |
Christian Lange
BRD | Director/Board Member | 46 | 01/09/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/06/24 | Don | Director | 767 | 0.0478% | ||
| 20/05/24 | Don | Director | 3,750 | 0.2335% | ||
| 28/03/24 | Sell | Director | 8,242 | 0.5133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.43% | +1.47% | - | - | 1.66Cr | ||
| +1.15% | -2.81% | +53.73% | +71.00% | 6.56TCr | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 6.04TCr | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 5.58TCr | ||
| -0.06% | -3.25% | +8.92% | +119.51% | 4.7TCr | ||
| -2.09% | -5.94% | +19.75% | +26.38% | 4.36TCr | ||
| -0.70% | +1.43% | +14.05% | +45.20% | 3.67TCr | ||
| -1.73% | -15.27% | +136.60% | +666.92% | 3.61TCr | ||
| -0.77% | -2.21% | +77.27% | +57.96% | 3.29TCr | ||
| -0.98% | +1.50% | -38.56% | +388.64% | 2.7TCr | ||
| Average | -1.00% | -1.71% | +33.61% | +172.36% | 4TCr | |
| Weighted average by Cap. | -0.90% | -1.48% | +33.34% | +147.52% |
Employees
1
















